Navigation Links
Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting

ts.

Discovery's lead product candidate, Surfaxin(r), is the subject of an Approvable Letter from the FDA for the prevention of Respiratory Distress Syndrome in premature infants. Surfaxin is also being developed for other neonatal and pediatric indications. Aerosurf(tm), Discovery's aerosolized SRT, is being developed to potentially obviate the need for intubation and conventional mechanical ventilation and holds the promise to significantly expand the use of surfactants in respiratory medicine. For more information, please visit our website at www.Discoverylabs.com.

To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Among the factors which could affect Discovery's actual results and could cause results to differ from those contained in these forward-looking statements are the risk that Discovery may not profitably develop and market its products, the risk that financial market conditions may change, the risk that Discovery will not be able to raise additional capital or enter into additional collaboration agreements, the risk that Discovery will not be able to attract or retain qualified personnel or timely provide for a successful sales and marketing organization, risks relating to the progress of Discovery's research and development,, risks in the FDA or other regulatory agency review process generally, including that such regulatory authority will not approve the marketing and sale of a drug product even after acceptance of an application or that approval by such regulatory agency may be withheld, delayed and/or limited by indications or other label limita
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
3. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
10. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated ... that on January 7, 2014, the Company,s board of ... Ben-Zion Weiner as its new member of the ...
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... Arias, M.D., Ph.D., at The University of Texas Health ... superbug that caused a bloodstream infection in a Brazilian ... of The New England Journal of Medicine . ... of highly-resistant bacteria known as methicillin-resistant Staphylococcus aureus ... hospital and community-associated infections. The superbug has also acquired ...
(Date:4/17/2014)... D.C. -- The world is less than 40 years ... implications for people and governments, according to a top ... the first time in human history, food production will ... of land, water and energy," said Dr. Fred Davies, ... security. "Food issues could become as politically destabilizing by ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2
... , , SAN DIEGO, ... reported financial results for the second quarter of 2009, including non-GAAP ... (STD), clinical diagnostics and total product sales. , , ... as a good performance from our core STD franchise, the inclusion ...
... , WASHINGTON, JULY 30 An estimated 4.1 million ... a House health reform bill, according to state-specific analysis of ... week by The Heritage Foundation . , ... a highly respected health care policy and management consulting firm, to examine ...
... expert says, might help keep elderly out of hospitals ... designed to increase muscle density in the elderly could ... suggests. , The contention stems from a study of ... about a five-year span, more than 55 percent of ...
... , , DALLAS , July ... provider of Internet-based claims processing solutions for the healthcare industry, today reported ... 2009. , , For the quarter ended June ... the $529,000 reported for the second quarter of 2008. Revenues for ...
... , , DALLAS, July 30 When ... Research Institute of Texas (CPRIT), they took a major step forward in ... $3 billion fund investing in cutting-edge, Texas-based research and commercialization projects aimed ... is a privilege for me to be part of CPRIT and to ...
... ... asthma patients to get a swine (H1N1) flu shot in addition to a seasonal flu ... for Disease Control and Prevention,s Vaccine Advisory Committee recommendations July 29 that identified people with ... ...
Cached Medicine News:Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 2Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 3Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 4Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 5Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 6Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 7Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 8Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 9Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 10Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 11Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 12Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 13Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 14Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 15Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 16Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 17Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 18Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 19Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 20Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 21Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 22Health News:Millions of Pennsylvanians Could Lose Private Insurance, Study Shows 2Health News:Muscle Density Linked to Disability 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 3Health News:Claimsnet.com Reports Second Quarter 2009 Results 4Health News:Texas on Top of Cancer Research: Dallas Regional Chamber Hosts Forum on New $3 Billion Fund 2Health News:Allergists Urge Asthmatics to Get Swine and Seasonal Flu Shots Following CDC Vaccine Advisory Committee Recommendations 2
XL STABI Hydrophilic Acrylic Lens....
XL OCTO Hydrophilic Acrylic Lens....
One piece multifocal acrylic intraocular lens....
MemoryLens Prefolded Acrylic Lens....
Medicine Products: